ZIVO BIOSCIENCE, INC. Employee Benefits and Share-based Compensation
ZIVO BIOSCIENCE, INC. (ZIVO) reported Employee Benefits and Share-based Compensation of $9.47 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2025-03-18
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for the quarter ending 2023-03-31 was $242.10K, a 57.57% decline year-over-year.
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for the quarter ending 2022-12-31 was $1.11M.
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for the quarter ending 2022-09-30 was $518.16K, a 424.46% increase year-over-year.
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for the quarter ending 2022-06-30 was $497.74K.
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for fiscal 2024 was $9.47M, a 992.23% increase from fiscal 2023.
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for fiscal 2023 was $867.36K, a 67.79% decline from fiscal 2022.
- ZIVO BIOSCIENCE, INC. employee benefits and share-based compensation for fiscal 2022 was $2.69M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2024-12-31 | $9.47M 10-K · filed 2025-03-18 | |||
| 2023-12-31 | $867.36K 10-K · filed 2025-03-18 | |||
| 2023-03-31 | $242.10K 10-Q · filed 2023-05-10 | $1.35M derived: sum of 2 quarters · filed 2024-03-15 | $1.87M derived: sum of 3 quarters · filed 2024-03-15 | $2.36M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.62M derived: sum of 2 quarters · filed 2024-03-15 | $2.12M derived: sum of 3 quarters · filed 2024-03-15 | $2.69M 10-K · filed 2024-03-15 |
| 2022-09-30 | $518.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.02M derived: sum of 2 quarters · filed 2022-11-14 | $1.59M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $497.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.07M 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | $570.63K 10-Q · filed 2023-05-10 | |||
| 2021-09-30 | $98.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.47M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $1.37M 10-Q · filed 2022-08-04 |